Maraviroc Compassionate Use.
Withdrawn prior to enrolment
Phase of Trial: Phase III
Latest Information Update: 06 May 2016
At a glance
- Drugs Maraviroc (Primary) ; Antiretrovirals
- Indications HIV-1 infections
- Focus Adverse reactions
- Sponsors Pfizer; ViiV Healthcare
- 10 Nov 2010 ViiV Healthcare added in associations field as reported by ClinicalTrials.gov.
- 10 Nov 2010 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 10 Nov 2010 Actual end date (May 2010) added as reported by ClinicalTrials.gov.